FrontierLab
A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

CONMED Corporation CNMD

Mixed   broader-coverage candidate · CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures.

On FrontierLab's discovery record since 2026-06-16 (9 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-25), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)4.4%
Gross margin53.6%
Gross profits / assets0.32
Rule of 4015.6
Net margin11.2%
Cash runway (months)
PEG
Price / sales0.9

Quality checklist

Fundamentals — snapshot as of 2026-07-25

StageEstablished
Share issuance (YoY)-1.7% · flat share count
Moat
TAM
P/E (trailing)24.1
EPS (trailing)$1.77
Burn multiple
Gross-margin trend (pts)-1.9
Cash / assets0.02
Net debt / EBITDA4.9
Statements as ofQ1 FY2026 · filed 2026-04-30

Momentum context — a snapshot from 2026-07-25, not current

Price at surface$42.68 (as of 2026-07-25)
52-week range$31.44 – $56.64
% off 52-wk high-24.6%
RSI (14)62
Relative volume0.4×

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-07-25 (end-of-day). How grades are computed →